This week, Wait Wait is live in Bloomington, Indiana with host Peter Sagal, special guest Lilly King and panelists Alonzo Bodden, Josh Gondelman, and Faith Salie ...

Hims & Hers Health began advertising a $49 Ozempic pill lookalike last week -- then stopped. Novo Nordisk charges $149 for its own Wegovy pills. Lilly charges $299 for Zepbound shots. First, on Friday ...

Eli Lilly's success rate in clinical trials was phenomenal last year. The drugmaker has made a big name for itself in diabetes and weight loss. But it's also proving innovative even beyond its core ...

Both Novo Nordisk and Eli Lilly are grappling with pricing pressure in the U.S., but their 2026 outlooks are diverging sharply. While Novo is bracing for a sales decline, Lilly sees revenue charging ...

“The older I get, I realize I have to make the most of what’s around to be of any use,” says Lilly Hiatt. The singer-songwriter and stellar heartland-rock bandleader feels more zen than ever these ...

After Novo Nordisk projected yesterday that its revenue could decline by as much as 13% in 2026, its share price has plummeted by 20%. Because the Danish company attributed much of the shortfall to ...

Eli Lilly posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soars. The ...

FRANKENMUTH, MI – The Royal Gift Shop at Bavarian Inn Restaurant will add Lilly Pulitzer to its offerings and host a launch party later this month to mark the occasion. The shop will hold the event on ...

Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash. Eli Lilly on Monday said Orna, which is dedicated to engineering immune ...

The Eli Lilly logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing ...

SHANGHAI, Feb 11 (Reuters) - Eli Lilly (LLY.N), opens new tab has won Chinese regulators' approval for its drug to treat chronic inflammatory bowel disease, expanding the treatment's use to the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Eli Lilly and Co. is buying a ...